Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
02/04/2026
Lindsay Corporation's second quarter operating revenue was $157.7 million, estimated at $171.3 million.
Latest
4 m ago
Russian oil and gas company said that during the recent heating season, Russia launched 129 attacks on Ukraine's natural gas and heating facilities.
4 m ago
American technology companies continue to announce increasing numbers of layoffs, with AI as the main driver.
5 m ago
According to Every Economic AI News, Dongwu Securities released a research report on April 2, giving Fangzheng Securities (601901.SH) a "buy" rating. The main reasons for the rating include: 1) a significant increase in brokerage business revenue, continuous improvement in digital service capabilities; 2) investment banking business still needs improvement; 3) rapid increase in asset management business scale; 4) high growth in investment income for the whole year, with significant volatility in Q4. (Daily Economic News)
5 m ago
According to the AI News of TodoEmprende, Huayuan Securities released a research report on April 2, giving a "buy" rating to Kelaiying (002821.SZ). The main reasons for this rating include: 1) Kelaiying is a globally leading CDMO one-stop comprehensive solution provider, dedicated to technological innovation and commercial application of global pharmaceutical processes; 2) the company achieves rapid growth in emerging businesses by leveraging industry resources and competitive advantages accumulated in the small molecule CDMO business sector; 3) high-order growth rate, emerging businesses contribute to order increments, and production capacity continues to be invested in. (Everyday Economic News)
5 m ago
The European Stoxx 600 index fell further to 1.6%, hitting a new intraday low.
See all latest
